Skip to main content
Year archive

Cipla Ltd. — 2025 filings

All 246 regulatory filings released by Cipla Ltd. (CIPLA) in 2025, sourced directly from the official regulator.

246 Filings
2025 Period
2025 filings (246)
Filing Released Lang
Change in Management
Board/Management Information
2025-12-30 English
Superannuation of Senior Management Personnel on 31st December 2025
Board/Management Information
2025-12-30 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-12-23 English
Board Meeting — Financial Results
Regulatory Filings
2025-12-23 English
Cipla Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 ,inter alia, to consider and approve the unaudited standalone and consolidated ....
Regulatory Filings
2025-12-23 English
Please find attached disclosure on ESG rating
Environmental & Social Information
2025-12-22 English
General Updates
Environmental & Social Information
2025-12-22 English
Cipla Limited has informed the exchange that it has entered into an exclusive supply and marketing agreement with Pfizer''s brands
Capital/Financing Update
2025-12-19 English
Arrangements for strategic, technical, manufacturing, or marketing tie up
Capital/Financing Update
2025-12-19 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-12-17 English
In compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee of the Company ....
Share Issue/Capital Change
2025-12-17 English
Product launch
Regulatory Filings
2025-12-10 English
Update on launch of Yurpeak (Tirzepatide) in India for the treatment of Obesity and Type 2 Diabetes
Regulatory Filings
2025-12-10 English
Please find attached disclosure on ESG rating
Environmental & Social Information
2025-12-10 English
General Updates
Regulatory Filings
2025-12-10 English
Update on acquisition of securities in Inzpera Healthsciences Limited
Capital/Financing Update
2025-12-04 English
Acquisition
Capital/Financing Update
2025-12-04 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Major Shareholding Notification
2025-12-01 English
Newspaper publication regarding special window for re- lodgement of transfer requests of physical shares
Interim / Quarterly Report H1 2026
2025-11-06 English
Copy of Newspaper Publication
Interim / Quarterly Report H1 2026
2025-11-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-11-03 English
We are enclosing hereby a copy of the transcript of the Company''s Q2 FY26 earning conference call dated 30th October, 2025.
Call Transcript
2025-11-03 English
Acquisition of securities in Inzpera Healthsciences Limited
M&A Activity
2025-11-03 English
Acquisition
M&A Activity
2025-11-03 English
Please find attached newspaper advertisement
Interim / Quarterly Report H1 2025
2025-10-31 English
Copy of Newspaper Publication
Report Publication Announcement
2025-10-31 English
Pursuant to Regulation 30 read with Part A of Schedule III and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the ....
Call Transcript
2025-10-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-10-30 English
Outcome of Board meeting dated 30th October, 2025
Board/Management Information
2025-10-30 English
Press Release
Interim / Quarterly Report Q2 2026
2025-10-30 English
Please find attached press release for Q2FY26
Interim / Quarterly Report Q2 2026
2025-10-30 English
Change in Director(s)
Board/Management Information
2025-10-30 English
Change in Management
Board/Management Information
2025-10-30 English
Outcome of Board Meeting
Board/Management Information
2025-10-30 English
Please find attached outcome of Board meeting
Board/Management Information
2025-10-30 English
Investor Presentation
Investor Presentation
2025-10-30 English
Investor Presentation for Q2FY26 dated 30th October, 2025
Investor Presentation
2025-10-30 English
Please find attached financial results for the quarter and half year ended 30th September, 2025
Interim / Quarterly Report H1 2025
2025-10-30 English
Outcome of Board Meeting
Interim / Quarterly Report H1 2025
2025-10-30 English
Please find attached financial results for the quarter and half year ended 30th September, 2025
Interim / Quarterly Report H1 2025
2025-10-30 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-10-29 English
In compliance with provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee ....
Share Issue/Capital Change
2025-10-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-10-23 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / ....
Regulatory Filings
2025-10-23 English
Product launch
Regulatory Filings
2025-10-23 English
Lilly and Cipla sign marketing and distribution agreement for second brand of Tirzepatide in India
Regulatory Filings
2025-10-23 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-10-19 English
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Regulatory Filings
2025-10-19 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings ....
Call Transcript
2025-10-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-10-13 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-09-24 English
Board Meeting — Financial Results
Board/Management Information
2025-09-24 English
Cipla Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2025 ,inter alia, to consider and approve the unaudited standalone and consolidated ....
Regulatory Filings
2025-09-24 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-09-12 English
In compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee of the Company ....
Share Issue/Capital Change
2025-09-12 English
General Updates
Regulatory Filings
2025-09-12 English
Please find attached disclosure on ESG rating
Regulatory Filings
2025-09-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-09-10 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / ....
Regulatory Filings
2025-09-10 English
Agreements
Major Shareholding Notification
2025-08-26 English
Update on acquisition of securities in iCaltech Innovations Private Limited.
Major Shareholding Notification
2025-08-26 English
Copy of Newspaper Publication
AGM Information
2025-08-19 English
Newspaper publication regarding 100 days campaign - "Saksham Niveshak"
AGM Information
2025-08-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-08-13 English
In furtherance to our intimation dated 30th June, 2025 and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the ....
Regulatory Filings
2025-08-13 English
General Updates
Environmental & Social Information
2025-08-11 English
Please find attached disclosure on ESG rating
Environmental & Social Information
2025-08-11 English
Update on USFDA Inspection at Company''s manufacturing facility in Bommasandra, Bengaluru, india
Regulatory Filings
2025-08-05 English
Updates
Regulatory Filings
2025-08-05 English
Copy of Newspaper Publication
Regulatory Filings
2025-08-02 English
Newspaper publication regarding Special Window for re-lodgement of transfer request of physical shares
Regulatory Filings
2025-08-02 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-08-02 English
In compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Operations and Administrative Committee of the Company on 2nd August, 2025 ....
Share Issue/Capital Change
2025-08-02 English
News Verification
Regulatory Filings
2025-08-01 English
Please find attached clarification.
Regulatory Filings
2025-08-01 English
Please find attached disclosure on ESG rating
Regulatory Filings
2025-07-29 English
General Updates
Environmental & Social Information
2025-07-29 English
We are enclosing herewith a copy of the transcript of the Company''s Q1 FY26 earning conference call dated 25th July, 2025
Call Transcript
2025-07-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-07-28 English
Please find attached newspaper advertisement
Interim / Quarterly Report Q1 2026
2025-07-26 English
Copy of Newspaper Publication
Interim / Quarterly Report Q1 2025
2025-07-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-07-25 English
Pursuant to Regulation 30 read with Part A of Schedule III and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the ....
Regulatory Filings
2025-07-25 English
Press Release for quarter ended 30th June, 2025
Interim / Quarterly Report Q1 2026
2025-07-25 English
Press Release
Interim / Quarterly Report Q1 2026
2025-07-25 English
Investor Presentation for Q1 dated 25th July, 2025
Investor Presentation
2025-07-25 English
Investor Presentation
Investor Presentation
2025-07-25 English
Grant of ESOPs/ESARs
Capital/Financing Update
2025-07-25 English
Outcome of Board Meeting
Regulatory Filings
2025-07-25 English
Financial results for quarter ended 30th June 2025
Interim / Quarterly Report Q1 2026
2025-07-25 English
Please find attached financial results for the quarter ended 30th June 2025
Interim / Quarterly Report Q1 2026
2025-07-25 English
Outcome of Board Meeting
Interim / Quarterly Report Q1 2026
2025-07-25 English
Please find enclosed transcript of 89th AGM
Call Transcript
2025-07-23 English
General Updates
AGM Information
2025-07-23 English
Acquisition
M&A Activity
2025-07-21 English
Acquisition of securities in iCaltech Innovations Private Limited
Capital/Financing Update
2025-07-21 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Major Shareholding Notification
2025-07-18 English
Appointment
Board/Management Information
2025-07-16 English
Please find attached intimation for appointment of Secretarial Auditors
Board/Management Information
2025-07-16 English
Proceeding of 89th Annual General Meeting
AGM Information
2025-07-16 English
Shareholders meeting
AGM Information
2025-07-16 English
Details of voting results of the 89th Annual General Meeting of the Company and Scrutiniser''s report
Declaration of Voting Results & Voting Rights Announcements
2025-07-16 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2025-07-16 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-07-14 English
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Regulatory Filings
2025-07-14 English
Please find attached disclosure on ESG Rating
Environmental & Social Information
2025-07-12 English
General Updates
Environmental & Social Information
2025-07-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-07-10 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings ....
Regulatory Filings
2025-07-10 English
Copy of Newspaper Publication
AGM Information
2025-07-02 English
Newspaper advertisement of notice of shareholders whose shares are liable to be transferred to Investor Education and Protection Fund("IEPF").
AGM Information
2025-07-02 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-07-01 English
Board Meeting — Financial Results
Board/Management Information
2025-07-01 English
Cipla Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2025 ,inter alia, to consider and approve the unaudited standalone and consolidated ....
Board/Management Information
2025-07-01 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / ....
Regulatory Filings
2025-06-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2025-06-30 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-06-27 English
In compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, the Operations and Adminstrative Committee of the Company on 26th June 2025 has allotted 43,396 fully paid up equity shares ....
Share Issue/Capital Change
2025-06-27 English
Copy of Newspaper Publication
Report Publication Announcement
2025-06-20 English
Enclosing herewith copies of newspaper advertisement published in Business Standards and Sakal today 20th June, 2025.
AGM Information
2025-06-20 English
Updates
Environmental & Social Information
2025-06-19 English
Please find attached BRSR for FR2024-25.
Environmental & Social Information
2025-06-19 English
Shareholders meeting
AGM Information
2025-06-19 English
Please find attached intimation.
Proxy Solicitation & Information Statement
2025-06-19 English
Please find enclosed Notice of 89th Annual General Meeting, Integrated Annual Report for FY 24-25
AGM Information
2025-06-19 English
Copy of Newspaper Publication
AGM Information
2025-06-12 English
Please find enclosed Newspaper advertisement titled "Notice of 89th AGM to be held through Video Conference, Record date and Final Dividend (including Special Dividend)" published in the ....
AGM Information
2025-06-12 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-06-07 English
Pursuant to Regulation 30 of SEBI(LODR) Regulations, 2015 the Operations and Administrative Committee of the Company on 7th June, 2025 has allotted 17,492 fully paid-up equity shares of ....
Share Issue/Capital Change
2025-06-07 English
General Updates
Regulatory Filings
2025-06-06 English
Please find enclosed disclosure on ESG rating.
Regulatory Filings
2025-06-06 English
Change in Management
Board/Management Information
2025-06-01 English
Intimation of appointment of Mr Prabhakarn Balakrishnan Nair as Senior Management Personnel and Global Chief Manufacturing Officer of the Company w.e.f. 1st July, 2025
Board/Management Information
2025-06-01 English
USFDA inspection at Company''s manufacturing facility in Bommasandra, Bengaluru, India
Regulatory Filings
2025-05-30 English
Updates
Regulatory Filings
2025-05-30 English
Please find the attached Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2025
Audit Report / Information FY 2025
2025-05-29 English
Update on acquisition of shares in AMPIN Energy C&I Eighteen Private Limited
Capital/Financing Update
2025-05-29 English
Agreements
Capital/Financing Update
2025-05-29 English
Incorporation
Regulatory Filings
2025-05-29 English
Intimation under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Capital/Financing Update
2025-05-29 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-05-26 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby notify that the Operations and Administrative Committee of the Company on 26th May 2025 allotted 49,931 fully paid ....
Share Issue/Capital Change
2025-05-26 English
Please find attached intimation
Regulatory Filings
2025-05-23 English
General Updates
Regulatory Filings
2025-05-23 English
Acquisition of shares in AMPIN Energy C&I Eighteen Private Limited
Capital/Financing Update
2025-05-19 English
Agreements
Capital/Financing Update
2025-05-19 English
Updates
Regulatory Filings
2025-05-17 English
Update on USFDA inspection at facility of Sitec Labs Limited in Mahape, Navi Mumbai, India
Regulatory Filings
2025-05-17 English
We are enclosing herewith copy of the transcript of the Company''s Q4 FY25 earning conference call dated 13th May 2025
Call Transcript
2025-05-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-05-16 English
Copy of Newspaper Publication
Report Publication Announcement
2025-05-14 English
Please find attached newspaper advertisement
Annual Report FY 2025
2025-05-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-05-13 English
Pursuant to Regulation 30 read with Part A of Schedule III and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the ....
Regulatory Filings
2025-05-13 English
Investor presentation for Q4 and FY 25 financial results
Investor Presentation
2025-05-13 English
General Updates
Investor Presentation
2025-05-13 English
Press Release
Interim / Quarterly Report Q4 2025
2025-05-13 English
Press Release for Q4 & FY 25 financial results
Interim / Quarterly Report Q4 2025
2025-05-13 English
Please find enclosed intimation on ESOP ESAR grant and AGM date
Regulatory Filings
2025-05-13 English
Appointment
Regulatory Filings
2025-05-13 English
General Updates
Regulatory Filings
2025-05-13 English
Please find enclosed intimation
Earnings Release FY 2025
2025-05-13 English
Outcome of Board Meeting
Annual Report
2025-05-13 English
Appointment
Audit Report / Information FY 2025
2025-05-13 English
Please find enclosed intimation
Audit Report / Information FY 2025
2025-05-13 English
Appointment
Regulatory Filings
2025-05-13 English
Please find enclosed intimation
Regulatory Filings
2025-05-13 English
Record date for payment of final dividend for FY 2024-25
Interim / Quarterly Report FY 2025
2025-05-13 English
Record Date
Annual Report
2025-05-13 English
Recommendation of Final dividend for 2024-25
Interim / Quarterly Report FY 2025
2025-05-13 English
Dividend
Regulatory Filings
2025-05-13 English
Outcome of Board Meeting
Annual Report
2025-05-13 English
Please find enclosed the result dated 13th May 2025
Interim / Quarterly Report FY 2025
2025-05-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-04-30 English
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the Management of the Company will ....
Regulatory Filings
2025-04-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-04-30 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / ....
Regulatory Filings
2025-04-30 English
Updates
Regulatory Filings
2025-04-29 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2025-04-29 English
Please find enclosed disclosure on ESG rating.
Environmental & Social Information
2025-04-24 English
General Updates
Environmental & Social Information
2025-04-24 English
Update on USFDA inspection at manufacturing facility of Medispray in Kundaim, Goa, India
Regulatory Filings
2025-04-17 English
Updates
Regulatory Filings
2025-04-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-04-17 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings ....
Earnings Release Q4 2025
2025-04-17 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-04-17 English
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 we hereby notify that the Operations and Administrative Committee ....
Share Issue/Capital Change
2025-04-17 English
Certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018
Regulatory Filings
2025-04-16 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-04-16 English
Company has received final approval from USFDA for ANDA submitted for Paclitaxel Protein-bound Particles for Injectable Suspension (albumin-bound), 100 mg/vial, Single-Dose Vial (''Protein-bound ....
Regulatory Filings
2025-04-11 English
Product launch
Regulatory Filings
2025-04-11 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-04-08 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2025-04-07 English
Cipla Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2025 ,inter alia, to consider and approve 1. the Standalone and Consolidated Audited ....
Regulatory Filings
2025-04-07 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-04-04 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-03-19 English
In compliance with the provisions of Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby notify that the Operations and Administrative Committee of the Company on 19th March, 2025 ....
Share Issue/Capital Change
2025-03-19 English
USFDA inspection at analytical testing facility of Sitec Labs Limited in Mahape, Navi Mumbai, India
Regulatory Filings
2025-02-20 English
Updates
Regulatory Filings
2025-02-20 English
Product launch
Regulatory Filings
2025-02-20 English
Company has received final approval from USFDA for NDA submitted for Nilotinib Capsules 50, 150 and 200 mg on 19th February, 2025
Regulatory Filings
2025-02-20 English
Update on investment in Cipla Medpro South Africa Proprietary Limited
Capital/Financing Update
2025-02-18 English
General Updates
Capital/Financing Update
2025-02-18 English
Investor Presentation
Investor Presentation
2025-02-18 English
In furtherance to our intimation dated 10th February, 2025, we are hereby enclosing investor presentation to be made at the Kotak Conference.
Investor Presentation
2025-02-18 English
In compliance with regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administration Committee of the Company ....
Share Issue/Capital Change
2025-02-13 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2025-02-13 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / ....
Regulatory Filings
2025-02-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-02-10 English
Update on USFDA Inspection at Company''s manufacturing facility in Virgonagar, Bengaluru, India
Regulatory Filings
2025-02-08 English
Updates
Regulatory Filings
2025-02-08 English
General Updates
Capital/Financing Update
2025-02-03 English
Investment in Cipla Medpro South Africa Proprietary Limited, wholly owned subsidiary
Capital/Financing Update
2025-02-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-01-31 English
We are enclosing herewith copy of the transcript of the Company''s Q3FY25 earnings conference call held on 28th January 2025. The transcript is also available on the website of the Company.
Call Transcript
2025-01-31 English
Please find attached newspaper publication
Interim / Quarterly Report 9M 2025
2025-01-29 English
Copy of Newspaper Publication
Interim / Quarterly Report 9M 2025
2025-01-29 English
Pursuant to Regulation 30 read with Part A of Schedule III and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the ....
Regulatory Filings
2025-01-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-01-28 English
Integrated Filing (Financial) - Unaudited Financial Results of Cipla Limited ("the Company") for the quarter and nine months ended 31st December, 2024
Interim / Quarterly Report 9M 2025
2025-01-28 English
Integrated Filing- Financial
Interim / Quarterly Report
2025-01-28 English
Change in Management
Board/Management Information
2025-01-28 English
Change in designation of SMP
Board/Management Information
2025-01-28 English
Outcome of Board Meeting dated 28th January, 2025
Board/Management Information
2025-01-28 English
Outcome of Board Meeting
Board/Management Information
2025-01-28 English
Please find attached Press release dated 28th January, 2025
Interim / Quarterly Report Q3 2025
2025-01-28 English
Press Release
Interim / Quarterly Report Q3 2025
2025-01-28 English
Investor Presentation
Investor Presentation
2025-01-28 English
Please find attached investor presentation dated 28th January, 2025.
Investor Presentation
2025-01-28 English
Unaudited Financial Results (standalone and consolidated) for the quarter and nine months ended 31st December, 2024.
Interim / Quarterly Report 9M 2025
2025-01-28 English
Financial Result Updates
Interim / Quarterly Report
2025-01-28 English
Change in Management
Board/Management Information
2025-01-23 English
Intimation for resignation of Mr Rajeev Kumar Sinha, Global Chief Manufacturing Officer and Senior Management Personnel.
Board/Management Information
2025-01-23 English
USFDA inspection at manufacturing facility of Medispray Laboratories Private Limited in Kundaim, Goa, India
Regulatory Filings
2025-01-20 English
Updates
Regulatory Filings
2025-01-20 English
Action(s) initiated or orders passed
Regulatory Filings
2025-01-17 English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2025-01-17 English
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Regulatory Filings
2025-01-15 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2025-01-15 English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2025-01-14 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings
2025-01-14 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings ....
Call Transcript
2025-01-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-01-08 English
Board Meeting — Financial Results
Regulatory Filings
2025-01-06 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-01-06 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 ,inter alia, to consider and approve the unaudited standalone and consolidated ....
Regulatory Filings
2025-01-06 English